Drug Shortage Report for MATULANE
| Report ID | 130922 |
| Drug Identification Number | 00012750 |
| Brand name | MATULANE |
| Common or Proper name | Procarbazine Hydrochloride |
| Company Name | LEADIANT BIOSCIENCES, INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PROCARBAZINE |
| Strength(s) | 50MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100s |
| ATC code | L01XB |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-01-25 |
| Actual start date | |
| Estimated end date | 2021-01-25 |
| Actual end date | 2021-01-25 |
| Shortage status | Resolved |
| Updated date | 2021-01-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2000 ELLESMERE ROAD SCARBOROUGH, ONTARIO CANADA M1H 2W4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2021-01-26 | English | Compare |
| v4 | 2021-01-25 | French | Compare |
| v3 | 2021-01-25 | English | Compare |
| v2 | 2021-01-07 | French | Compare |
| v1 | 2021-01-07 | English | Compare |
Showing 1 to 5 of 5